Soluble Mesothelin-Related Peptide and Osteopontin As Markers of Response in Malignant Mesothelioma

Abstract

Percentage changes in SMRP levels, but not changes in OP levels, are a potentially useful marker of disease course. These findings should be validated prospectively for a role as an objective adjunctive measure of disease course in both clinical trials and clinical practice.